Earnings

HCA Healthcare Raises FY2026 GAAP EPS Guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 Est; Raises FY2026 Sales Guidance from $77.000B-$79.500B to $78.250B-$79.500B vs $78.517B Est

Oct 27, 2026 · 07:06 AM ET· updated 2h ago

HCA Healthcare (NYSE:HCA) raises FY2026 GAAP EPS guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 analyst estimate. Raises FY2026 sales outlook from $77.000 billion-$79.500 billion to $78.250 billion-$79.500

Why It Matters

HCA Healthcare raised its money and profit forecasts for next year. This shows the company expects to do better than many people predicted.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

HCA476.69

+11.43 (+2.46%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.